Kiri Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 5:01 pm

Quick Insight

Kiri Industries Ltd, operating in the dyes and pigments sector, currently trades at ₹568, reflecting a market capitalization of ₹3,161 crore. With a price-to-earnings (P/E) ratio of 11.9, the stock appears undervalued compared to the industry average, potentially attracting value investors. However, the company's return on equity (ROE) of 8.74% and return on capital employed (ROCE) of just 0.45% raise concerns about profitability and efficient capital usage. Notably, the negative operating profit margin (OPM) of -2% and interest coverage ratio (ICR) of -0.15x suggest that Kiri may struggle to manage its debt of ₹1,124 crore effectively. Despite a robust reserve of ₹3,191 crore, the low price-to-book value (P/BV) of 0.55x indicates a significant market discount. Given these metrics, investors should exercise caution, as operational

Competitors of Kiri Industries Ltd

All Competitor Stocks of Kiri Industries Ltd

Quarterly Result

Last Updated: May 31, 2025, 8:40 am

Below is a detailed analysis of the quarterly data for Kiri Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 205.00 Cr.. The value appears strong and on an upward trend. It has increased from 179.00 Cr. (Dec 2024) to 205.00 Cr., marking an increase of 26.00 Cr..
• For Expenses, as of Mar 2025, the value is 210.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 223.00 Cr. (Dec 2024) to 210.00 Cr., marking a decrease of 13.00 Cr..
• For Operating Profit, as of Mar 2025, the value is -5.00 Cr.. The value appears strong and on an upward trend. It has increased from -44.00 Cr. (Dec 2024) to -5.00 Cr., marking an increase of 39.00 Cr..
• For OPM %, as of Mar 2025, the value is -2.00%. The value appears strong and on an upward trend. It has increased from -25.00% (Dec 2024) to -2.00%, marking an increase of 23.00%.
• For Other Income, as of Mar 2025, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 92.00 Cr. (Dec 2024) to 6.00 Cr., marking a decrease of 86.00 Cr..
• For Interest, as of Mar 2025, the value is 54.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 50.00 Cr. (Dec 2024) to 54.00 Cr., marking an increase of 4.00 Cr..
• For Depreciation, as of Mar 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 11.00 Cr..
• For Profit before tax, as of Mar 2025, the value is -64.00 Cr.. The value appears to be declining and may need further review. It has decreased from -14.00 Cr. (Dec 2024) to -64.00 Cr., marking a decrease of 50.00 Cr..
• For Tax %, as of Mar 2025, the value is 0.00%. The value appears to be improving (decreasing) as expected. It has decreased from 1.00% (Dec 2024) to 0.00%, marking a decrease of 1.00%.
• For Net Profit, as of Mar 2025, the value is -85.00 Cr.. The value appears to be declining and may need further review. It has decreased from 177.00 Cr. (Dec 2024) to -85.00 Cr., marking a decrease of 262.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is -15.22. The value appears to be declining and may need further review. It has decreased from 31.80 (Dec 2024) to -15.22, marking a decrease of 47.02.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 5:00 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:50 am

Below is a detailed analysis of the balance sheet data for Kiri Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 56.00 Cr.. The value appears strong and on an upward trend. It has increased from 52.00 Cr. (Mar 2024) to 56.00 Cr., marking an increase of 4.00 Cr..
• For Reserves, as of Mar 2025, the value is 3,191.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,760.00 Cr. (Mar 2024) to 3,191.00 Cr., marking an increase of 431.00 Cr..
• For Borrowings, as of Mar 2025, the value is 1,124.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 122.00 Cr. (Mar 2024) to 1,124.00 Cr., marking an increase of 1,002.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 355.00 Cr.. The value appears to be improving (decreasing). It has decreased from 478.00 Cr. (Mar 2024) to 355.00 Cr., marking a decrease of 123.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 4,725.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,411.00 Cr. (Mar 2024) to 4,725.00 Cr., marking an increase of 1,314.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 806.00 Cr.. The value appears strong and on an upward trend. It has increased from 470.00 Cr. (Mar 2024) to 806.00 Cr., marking an increase of 336.00 Cr..
• For CWIP, as of Mar 2025, the value is 63.00 Cr.. The value appears to be declining and may need further review. It has decreased from 73.00 Cr. (Mar 2024) to 63.00 Cr., marking a decrease of 10.00 Cr..
• For Investments, as of Mar 2025, the value is 3,152.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,213.00 Cr. (Mar 2024) to 3,152.00 Cr., marking an increase of 939.00 Cr..
• For Other Assets, as of Mar 2025, the value is 705.00 Cr.. The value appears strong and on an upward trend. It has increased from 655.00 Cr. (Mar 2024) to 705.00 Cr., marking an increase of 50.00 Cr..
• For Total Assets, as of Mar 2025, the value is 4,725.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,411.00 Cr. (Mar 2024) to 4,725.00 Cr., marking an increase of 1,314.00 Cr..

Notably, the Reserves (3,191.00 Cr.) exceed the Borrowings (1,124.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Kiri Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 25.55. This value is within the healthy range. It has increased from 20.67 (Mar 23) to 25.55, marking an increase of 4.88.
• For Diluted EPS (Rs.), as of Mar 24, the value is 25.55. This value is within the healthy range. It has increased from 20.67 (Mar 23) to 25.55, marking an increase of 4.88.
• For Cash EPS (Rs.), as of Mar 24, the value is -7.57. This value is below the healthy minimum of 3. It has increased from -10.82 (Mar 23) to -7.57, marking an increase of 3.25.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 542.45. It has increased from 516.89 (Mar 23) to 542.45, marking an increase of 25.56.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 542.45. It has increased from 516.89 (Mar 23) to 542.45, marking an increase of 25.56.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 183.12. It has increased from 182.32 (Mar 23) to 183.12, marking an increase of 0.80.
• For PBDIT / Share (Rs.), as of Mar 24, the value is -0.67. This value is below the healthy minimum of 2. It has increased from -6.59 (Mar 23) to -0.67, marking an increase of 5.92.
• For PBIT / Share (Rs.), as of Mar 24, the value is -10.05. This value is below the healthy minimum of 0. It has increased from -16.02 (Mar 23) to -10.05, marking an increase of 5.97.
• For PBT / Share (Rs.), as of Mar 24, the value is -14.46. This value is below the healthy minimum of 0. It has increased from -17.23 (Mar 23) to -14.46, marking an increase of 2.77.
• For Net Profit / Share (Rs.), as of Mar 24, the value is -16.96. This value is below the healthy minimum of 2. It has increased from -20.25 (Mar 23) to -16.96, marking an increase of 3.29.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 25.66. This value is within the healthy range. It has increased from 20.58 (Mar 23) to 25.66, marking an increase of 5.08.
• For PBDIT Margin (%), as of Mar 24, the value is -0.36. This value is below the healthy minimum of 10. It has increased from -3.61 (Mar 23) to -0.36, marking an increase of 3.25.
• For PBIT Margin (%), as of Mar 24, the value is -5.49. This value is below the healthy minimum of 10. It has increased from -8.78 (Mar 23) to -5.49, marking an increase of 3.29.
• For PBT Margin (%), as of Mar 24, the value is -7.89. This value is below the healthy minimum of 10. It has increased from -9.45 (Mar 23) to -7.89, marking an increase of 1.56.
• For Net Profit Margin (%), as of Mar 24, the value is -9.25. This value is below the healthy minimum of 5. It has increased from -11.10 (Mar 23) to -9.25, marking an increase of 1.85.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 14.01. This value is within the healthy range. It has increased from 11.28 (Mar 23) to 14.01, marking an increase of 2.73.
• For Return on Networth / Equity (%), as of Mar 24, the value is 4.73. This value is below the healthy minimum of 15. It has increased from 3.98 (Mar 23) to 4.73, marking an increase of 0.75.
• For Return on Capital Employeed (%), as of Mar 24, the value is -1.83. This value is below the healthy minimum of 10. It has increased from -3.04 (Mar 23) to -1.83, marking an increase of 1.21.
• For Return On Assets (%), as of Mar 24, the value is 3.89. This value is below the healthy minimum of 5. It has increased from 3.33 (Mar 23) to 3.89, marking an increase of 0.56.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.01.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.04. This value is within the healthy range. It has increased from 0.01 (Mar 23) to 0.04, marking an increase of 0.03.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.28. It has decreased from 0.30 (Mar 23) to 0.28, marking a decrease of 0.02.
• For Current Ratio (X), as of Mar 24, the value is 0.98. This value is below the healthy minimum of 1.5. It has decreased from 1.13 (Mar 23) to 0.98, marking a decrease of 0.15.
• For Quick Ratio (X), as of Mar 24, the value is 0.62. This value is below the healthy minimum of 1. It has decreased from 0.71 (Mar 23) to 0.62, marking a decrease of 0.09.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 3.04. This value is below the healthy minimum of 4. It has increased from 2.75 (Mar 23) to 3.04, marking an increase of 0.29.
• For Interest Coverage Ratio (X), as of Mar 24, the value is -0.15. This value is below the healthy minimum of 3. It has increased from -5.41 (Mar 23) to -0.15, marking an increase of 5.26.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is -2.85. This value is below the healthy minimum of 3. It has increased from -15.63 (Mar 23) to -2.85, marking an increase of 12.78.
• For Enterprise Value (Cr.), as of Mar 24, the value is 1,599.98. It has increased from 1,416.91 (Mar 23) to 1,599.98, marking an increase of 183.07.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.69. This value is within the healthy range. It has increased from 1.50 (Mar 23) to 1.69, marking an increase of 0.19.
• For EV / EBITDA (X), as of Mar 24, the value is -460.34. This value is below the healthy minimum of 5. It has decreased from -41.50 (Mar 23) to -460.34, marking a decrease of 418.84.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.66. This value is within the healthy range. It has increased from 1.56 (Mar 23) to 1.66, marking an increase of 0.10.
• For Price / BV (X), as of Mar 24, the value is 0.55. This value is below the healthy minimum of 1. It has increased from 0.54 (Mar 23) to 0.55, marking an increase of 0.01.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.66. This value is within the healthy range. It has increased from 1.56 (Mar 23) to 1.66, marking an increase of 0.10.
• For EarningsYield, as of Mar 24, the value is 0.08. This value is below the healthy minimum of 5. It has increased from 0.07 (Mar 23) to 0.08, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness